Owkin

What is Owkin?

Owkin is a company building AI for biopharma R&D and clinical research, with the stated aim of an autonomous AI Scientist. Its main product, K Pro, is an AI agent that works as a decision-support tool for pharmaceutical research.

Key capabilities of Owkin

• Clinical trial decisions: supports trial design and decision-making
• Patient stratification: segments patients and populations
• Portfolio evaluation: early assessment of drug portfolios
• Biomarker discovery: multi-omic biomarker discovery
• Multimodal analysis: works across multimodal patient data
• Fast answers: vendor says answers in minutes instead of hours

How Owkin works

K Pro is trained on extensive multimodal patient data, findings are explored through wet lab validation, and oncologists and biologists worldwide refine results that feed back into the system. The loop is designed to improve the agent over time while experts stay in the validation step.

Who uses Owkin?

Pharmaceutical and biotech teams working on drug discovery, clinical development and population health. Owkin operates from Paris, New York and Geneva and works through affiliates Epkin, Waiv and Bioptimus.

Owkin pricing

Owkin does not publish pricing for K Pro on its homepage, and access is arranged with the vendor.

Owkin alternatives

BenchSci and Insilico Medicine focus on AI for preclinical and drug discovery research, LatchBio provides bioinformatics workflows, and Saama targets clinical data.